| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000034752 |
| Receipt No. | R000039626 |
| Scientific Title | A study for an effect of the food containing plant-derived ingredient on blood glucose level(SBF-2018-06-MMLIY) |
| Date of disclosure of the study information | 2018/11/05 |
| Last modified on | 2019/08/05 (Ver. 2) |
| Basic information | ||
| Public title | A study for an effect of the food containing plant-derived ingredient on blood glucose level(SBF-2018-06-MMLIY) | |
| Acronym | A study for an effect of the food containing plant-derived ingredient on blood glucose level | |
| Scientific Title | A study for an effect of the food containing plant-derived ingredient on blood glucose level(SBF-2018-06-MMLIY) | |
| Scientific Title:Acronym | A study for an effect of the food containing plant-derived ingredient on blood glucose level | |
| Region |
|
|
| Condition | ||
| Condition | Not applicable | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate an effect of the food containing plant-derived ingredient on blood glucose level |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Efficacy : Area under the curve of blood glucose level, fasting blood glucose, HbA1c, HOMA-IR
Safety : Incidence of adverse effects |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Functional food(low dose), 12 weeks | |
| Interventions/Control_2 | Functional food(high dose), 12 weeks | |
| Interventions/Control_3 | Food without functional food, 12 weeks | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1)Healthy male and female whose age are 20 <= years old <65.
(2)Subjects who are able to submit the written informed consents. |
|||
| Key exclusion criteria | (1)Females in pregnancy, lactation and scheduled pregnancy period.
(2)Subjects who are attending other studies or attended other studies within past 4 weeks. (3)With present heart disorder, liver disorder, or kidney disorder (4)With previous or present cardiac disorder (5)With diabetes mellitus, or (6)Subjects who are deemed to be unsuitable by the investigator. |
|||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Suntory Beverage & Food Limited | ||||||
| Division name | Development and Design Department | ||||||
| Zip code | |||||||
| Address | 13-2 Imaikamicho, Nakahara, Kawasaki, Kanagawa, 211-0067 Japan | ||||||
| TEL | 050-3182-6114 | ||||||
| Takanori_Teramoto@suntory.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Suntory Beverage & Food Limited | ||||||
| Division name | Development and Design Department | ||||||
| Zip code | |||||||
| Address | 13-2 Imaikamicho, Nakahara, Kawasaki, Kanagawa, 211-0067 Japan | ||||||
| TEL | 050-3182-6114 | ||||||
| Homepage URL | |||||||
| Hiroyuki_Kato@suntory.co.jp | |||||||
| Sponsor | |
| Institute | Suntory Beverage & Food Limited |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Suntory Beverage & Food Limited |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039626 |